Home › Funds › Versant Venture Management, LLC › SKYE

Versant Venture Management, LLC position in SKYE

Skye Bioscience, Inc. · Health Care

Versant Venture Management, LLC reported holding 250,962 shares of SKYE (Skye Bioscience, Inc.) in its Q3 2026 13F filing — a position valued at US$404K, representing 0.37% of its reported portfolio and ranking #7 among its reported holdings. Versant Venture Management, LLC has disclosed SKYE holdings in 11 of the last 11 reported quarters, going back to Q1 2024.

Latest position (Q3 2026)250.96K sh
Reported value held$404.05K
Portfolio Weight0.37%
First reportedQ1 2024
Last changeReduce
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How Versant Venture Management, LLC's SKYE position evolved

Versant Venture Management, LLC first disclosed a stake in SKYE in Q1 2024 at 2,007,702 shares (US$31.4M). Across 11 filings, Versant Venture Management, LLC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 9 time(s). The most recent filing (Q3 2026) shows 250,962 shares valued at US$404K — a reduction of -1,756,742 shares quarter over quarter.. Notable position changes include a 88% trim in Q3 2026 (shares fell 32% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2024 2.01M $31.40M New
Q2 2024 2.01M $16.08M Hold
Q3 2024 2.01M $7.85M Hold
Q4 2024 2.01M $5.68M Hold
Q1 2025 2.01M $3.19M Hold
Q2 2025 2.01M $8.39M Hold
Q3 2025 2.01M $7.89M Hold
Q4 2025 2.01M $1.51M Hold
Q1 2026 2.01M $1.23M Hold
Q2 2026 2.01M $1.39M Hold
Q3 2026 250.96K $404.05K Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About SKYE and 13F data

SKYE (Skye Bioscience, Inc.) is a Health Care company. 17 other funds we track also report a position in SKYE — the largest reported positions include 5AM Venture Management, LLC (US$6.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding SKYE

All SKYE fund holders →

FAQ

How long has Versant Venture Management, LLC held SKYE?

Versant Venture Management, LLC has disclosed SKYE holdings in 11 of the last 11 reported quarters, going back to Q1 2024.

What is Versant Venture Management, LLC's current position in SKYE?

As of Q3 2026, Versant Venture Management, LLC holds 250.96K shares of SKYE (Skye Bioscience, Inc.), valued at $404.05K, representing 0.37% of its reported portfolio and ranking #7.

Has Versant Venture Management, LLC been buying or selling SKYE?

In the latest 13F filing (Q3 2026), Versant Venture Management, LLC reduced its position in SKYE.

Which other funds hold SKYE?

Other major institutional holders of SKYE include 5AM Venture Management, LLC, among 17 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.